Clinical Development

VANCOUVER, British Columbia — September 16, 2026 AbCellera announced that it will present Phase 2 efficacy and safety data...

Seattle, Washington, U.S., September 15, 2026 HDT Bio Corp. has received an ARPA-H GIVE award to lead the development...

Toronto, Ontario, Canada, September 16, 2026 Thryv Therapeutics has announced the publication of new research in JACC: Heart Failure...

LONDON and NEW YORK — September 15, 2026 Compass Pathways plc announced the launch of Change the Tune in...

Indianapolis, Indiana, September 15, 2026 Elanco Animal Health is reporting continued momentum in its pet health innovation portfolio as...

Los Angeles, California, September 15, 2026 Summit Therapeutics has announced positive overall survival results from the Phase 3 HARMONi-2...

SAN DIEGO, Calif. — September 15, 2026 Connect Biopharma Holdings Limited announced positive preliminary topline results from the global...

NORWOOD, Mass. — September 14, 2026 Corbus Pharmaceuticals Holdings, Inc. announced positive topline results from its CANYON-1 Phase 1b...

TEL AVIV, Israel — September 14, 2026 Nasus Pharma Ltd. announced that the U.S. Food and Drug Administration (FDA)...

Indianapolis, Indiana, September 15, 2026 Eli Lilly and Company will present new clinical and scientific data for Foundayo (orforglipron),...